Related Experiment Video
Updated: Feb 1, 2026

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
Pretreatment cerebral microbleeds and symptomatic intracerebral hemorrhage post-thrombolysis: a systematic review and
Jiangzhi Yan1, Jianting Qiu1, Xiumei Wu1
1Department of Neurology, Cerebrovascular Disease Center, People's Hospital, China Medical University, 33 Wenyi Road, Shenhe District, Shenyang, 110016, People's Republic of China.
Background And Purpose:
Cerebral microbleeds (CMBs) are a possible predictor of symptomatic intracranial hemorrhage (sICH) and poor function outcome (PFO). We aimed to investigate the presence of CMBs on increased incidence of sICH and PFO in acute ischemic stroke patients receiving intravenous thrombolysis (IVT) treatment.
Methods:
We searched PubMed, EMBASE, and Cochrane Library from 1 January 1997 to 13 May 2018, for relevant studies and calculated the pooled relative risk (RR) for the incidence of sICH and PFO in patients with CMBs versus those without after IVT.
Results:
We included 2407 participants from nine studies. The cumulative sICH incidence was higher in patients with CMBs (6%, 95% CI 4-8%) than that in patients without CMBs (4%, 95% CI 2-6%) with pooled RR 1.51 (95% CI, 1.04-2.21; P = 0.031). Four studies including 1550 patients reported data on 3- to 6-month PFO. The cumulative PFO incidence was higher in patients with CMBs (53%, 95% CI 47-59%) than that in patients without CMBs (41%, 95% CI 36-46%) with pooled RR 1.25 (95% CI 1.11-1.41; P = 0.000).
Conclusions:
The pretreatment CMBs were associated with increased incidence of sICH and PFO in acute ischemic stroke patients receiving IVT. However, it was not convincing enough to set the presence of CMBs as contraindication to IVT.
Insights
Cerebral microbleeds (CMBs) in acute ischemic stroke patients predict higher rates of symptomatic intracranial hemorrhage and poor functional outcomes after intravenous thrombolysis (IVT). CMBs do not currently contraindicate IVT treatment.
Area of Science:
- Neurology
- Radiology
- Stroke Medicine
Background:
- Cerebral microbleeds (CMBs) are increasingly recognized as potential indicators of hemorrhagic complications.
- Predicting outcomes in acute ischemic stroke patients undergoing treatment is crucial for clinical decision-making.
Purpose of the Study:
- To investigate the association between pretreatment cerebral microbleeds (CMBs) and the incidence of symptomatic intracranial hemorrhage (sICH) and poor functional outcome (PFO).
- To evaluate the impact of CMBs on patients with acute ischemic stroke receiving intravenous thrombolysis (IVT).
Main Methods:
- A systematic literature search was conducted across PubMed, EMBASE, and Cochrane Library databases.
- Meta-analysis was performed to calculate pooled relative risks (RR) for sICH and PFO in patients with and without CMBs post-IVT.
- Data from nine studies encompassing 2407 participants were included.
Main Results:
- Patients with CMBs showed a significantly higher incidence of sICH (6% vs. 4%, RR 1.51) compared to those without CMBs.
- A higher cumulative incidence of poor functional outcome (PFO) at 3-6 months was observed in patients with CMBs (53% vs. 41%, RR 1.25).
- The findings were based on data from 2407 participants across nine studies.
Conclusions:
- Pretreatment cerebral microbleeds are associated with an increased risk of symptomatic intracranial hemorrhage and poor functional outcomes following IVT for acute ischemic stroke.
- While CMBs indicate higher risk, they are not yet considered a definitive contraindication for IVT treatment.
- Further research may refine the role of CMBs in guiding IVT decisions.
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Random and Systematic Errors
Directing Effect of Substituents: meta-Directing Groups
Systematic Sampling Method
Systematic sampling is one of the simplest methods...
Propagation of Uncertainty from Systematic Error

